Stefan Meister is Waypoint’s Vice-Chairman, a position he has held since the start of 2021, and a non-executive member of its Board. Prior to this he spent close to a decade as Waypoint’s Group Chief Operating Officer and Member of the Board, taking, in that period, operating leadership and helping to drive the strategic development of the group in close cooperation with Mr. Ernesto Bertarelli.
Stefan chairs the the Board of Affidea – formerly Euromedic – the leading provider of Advanced Diagnostics Imaging and Cancer Care services in Europe, as well as acting as a Director of Stallergenes-Greer, the worldwide leader in allergy immunotherapy.
He joined Waypoint from Haniel Group where, over a 16 year period, he gathered extensive experience as the Group's CFO and Member of the Management Board and as General Manager of group affiliates. Stefan started his working career in 1991 at Novartis AG (Basel), holding various positions including a role as Head of Divisional Controlling for the Pharma Division.
Since 2010 he has been a member of the Board of Directors of Straumann - a global leader in implant, restorative and regenerative dentistry. Since the autumn of 2010 he has been a member of the Advisory Board of BPN (Business Professionals Network) in Bern, which supports the development of small and medium enterprises in developing countries. He is also a Member of the Advisory Board of the Center for Leadership and Value in Society at the University of St. Gallen and a member of the "Schweizer Dialog", an initiative at the same university that aims to build a network of leaders in business and politics that aims to instil sustainable values in society.
He is Swiss and holds an Economics degree from Basel University.
He is married and has two sons.